Skyscape Web Viewer : The Maudsley Prescribing Guidelines in Psychiatry : Main Index

View All
Dardorexant Psychotropics in overdose use in patients with renal impairment use in patients with hepatic impairment
Daridorexant use in patients with hepatic impairment in overdose use in patients with renal impairment
Database studies, antidepressant-associated hyponatraemia
Decision making, relational aspects
deep brain stimulation (DBS) 137 Obsessive compulsive disorder (OCD) and body dysmorphic disorder (BDD) in children and adolescents Alternatives to clozapine
Delayed doses of aripiprazole long-acting injection
Delirium
Demecolycline
dementia with Lewy bodies (DLB) 630 Parkinson's disease Dementia
Dependence definition/diagnosis dependence syndrome, definition
Depot antipsychotic medications Antipsychotic depots/long-acting injections comparison of types General introduction Paliperidone palmitate long-acting injection prescribing advice restarting after period of non-compliance site of administration of intramuscular injections Antipsychotic prophylaxis doses and frequencies improving adherence and outcomes pharmacokinetics reduction of schizophrenia
Depression/anhedonia from abstinence
Detoxification
Deutetrabenazine hepatic impairment for tardive dyskinesia renal impairment
Dexamfetamine, attention deficit hyperactivity disorder in adults
Diabetes mellitus antidepressants comorbid depression increasing if insufficient response antipsychotic-related dosing
dialectical behaviour therapy (DBT)
Diazepam benzodiazepines concentration in normal dosing and UK legal limit with alcohol Acutely disturbed or violent behaviour benzodiazepine withdrawal switching from benzodiazepines
Diphenhydramine, clozapine-induced hypersalivation
direct-acting oral anticoagulants (DOACs) citalopram/escitalopram not affecting renal function assessment atrial fibrillation patients possible SSRI interactions
Discontinuation Dementia Antipsychotic prophylaxis
Discontinuation of reducing dose for
Discontinuation syndrome, donepezil
Disinhibition clinical implications mechanism subjective reports benzodiazepines incident rates risk factors
Disruptive mood dysregulation disorder relationship
disulfiram (Antabuse), preventing relapse after alcohol detoxification
Diversion and misuse of prescribed drugs opioids stimulants for ADHD in adults
Donepezil alzheimerâ™s disease treatment for tardive dyskinesia
Dopaminergic agents and dopamine partial agonists, possible effects on impulse control disorders
Dose-related adverse drug effects, increased in hepatic impairment